Why the study?
Some pediatric cardiac fibromas are unresectable due to the impossibility of preserving normal cardiac anatomy or function, making orthotopic heart transplantation an exceptional alternative.
Does orthotopic heart transplantation improve outcomes in infants with giant unresectable cardiac fibromas?
Does orthotopic heart transplantation improve outcomes in infants with giant unresectable cardiac fibromas?
Orthotopic heart transplantation is a viable and effective definitive therapy for infants with giant, unresectable cardiac fibromas that pose a risk of life-threatening complications.
Answers are grounded in this paper and cite their sources.
May warrant surgical resection for symptomatic or high-risk pediatric cardiac fibromas; leaves open optimal management of asymptomatic lesions.
Cardiac fibromas (CF) are the second most common cardiac tumors in children. They can be aggressive tumors despite their benign histopathologic nature, accounting for the highest mortality rate among primary cardiac tumors. CF usually show a progressive growth and spontaneous regression is rare. Therefore, a complete surgical excision is the preferred therapeutic approach when patients become symptomatic or if mass-related life-threatening complications are anticipated, even in asymptomatic patients. However, some cases are not good candidates for surgical excision due to the impossibility of preserving a normal cardiac anatomy or function after the tumor resection. Orthotopic heart transplantation (OHT) can be an exceptional but adequate alternative for some giant unresectable CF in children. In this article, we report our experience with the case of a 7-month-old infant with a giant unresectable cardiac fibroma who was successfully managed through OHT.
No takes yet. Share an insight, caveat, or question.
Rodríguez‐González et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: